Shanghai Jincheng Suez Pharmaceutical

Shanghai Jincheng Suzhi Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Shandong Jincheng Pharmaceutical Group, is a pharmaceutical company specializing in the composite research, development, and manufacturing of traditional Chinese and Western medicines. Established in 1993 and located in the Jinshan Industrial Zone of Shanghai, the company features advanced production lines with an annual capacity of up to 2 billion units across various oral solid dosage forms, including tablets, capsules, granules, and dry suspensions. Its commercial portfolio highlights key products such as cefaclor dispersible tablets, cefalexin dry suspension, bisoprolol fumarate tablets, and coriolus versicolor extract capsules. In addition to its own product lines, the company operates as a Contract Manufacturing Organization (CMO), providing high-quality commercial manufacturing services for cephalosporins and general oral solid formulations. Through its integration into the Jincheng Pharmaceutical Group, the company plays a vital role in the group's comprehensive healthcare and pharmaceutical industry chain.